Bottom line
How much do FTXH and RYHIX overlap?
52% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 54.2% of FTXH's assets and 19.6% of RYHIX's. They share a meaningful core but differ in the rest of the portfolio.
RYHIX holds far more positions (135 vs 51), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FTXH and RYHIX have in common
| Holding | % of FTXH | % of RYHIX | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 7.77% | 3.63% | 3.63% |
| Abbvie Inc ABBV | 7.39% | 2.52% | 2.52% |
| Merck & Company Inc MRK | 7.07% | 2.04% | 2.04% |
| Johnson & Johnson JNJ | 6.96% | 2.88% | 2.88% |
| Bristol-myers Squibb Company BMY | 6.29% | 1.22% | 1.22% |
| Cardinal Health Inc CAH | 3.53% | 0.86% | 0.86% |
| Vertex Pharmaceuticals Inc VRTX | 3.41% | 1.34% | 1.34% |
| Amgen Inc AMGN | 3.18% | 1.56% | 1.56% |
| Pfizer Inc PFE | 2.97% | 1.25% | 1.25% |
| Gilead Sciences Inc GILD | 2.89% | 1.39% | 1.39% |
| Regeneron Pharmaceuticals Inc REGN | 2.72% | 0.90% | 0.90% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FTXH
- Biogen Inc — 3.84%
- Viatris Inc — 3.62%
- United Therapeutics Corp — 2.72%
- Jazz Pharmaceuticals Plc — 2.49%
- Incyte Corp — 2.39%
- Illumina Inc — 1.98%
- Zoetis Inc — 1.87%
- Exelixis Inc — 1.72%
- Charles River Laboratories International Inc — 1.49%
- Medpace Holdings Inc — 1.41%
- Ptc Therapeutics Inc — 1.37%
- Neurocrine Biosciences Inc — 1.37%
- Alkermes Plc — 1.35%
- Halozyme Therapeutics Inc — 1.21%
Only in RYHIX
- Unitedhealth Group Inc — 2.22%
- Thermo Fisher Scientific Inc — 1.61%
- Abbott Laboratories — 1.42%
- Cvs Health Corp — 1.31%
- Intuitive Surgical Inc — 1.31%
- Danaher Corp — 1.30%
- Stryker Corp — 1.21%
- Mckesson Corp — 1.05%
- Elevance Health Inc — 1.02%
- Cigna Group (the) — 0.94%
- Hca Healthcare Inc — 0.87%
- Boston Scientific Corp — 0.86%
- Edwards Lifesciences Corp — 0.84%
- Novo Nordisk A/s — 0.83%
Asset mix
| Asset type | FTXH | RYHIX |
|---|---|---|
| Stocks | 99.9% | 83.2% |
| Repurchase agreements | — | 0.9% |
| Cash & short-term funds | 0.1% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | FTXH | RYHIX |
|---|---|---|
| US | 95.6% | 73.0% |
| IE | 3.8% | 3.3% |
| CH | — | 2.3% |
| GB | — | 1.8% |
| DK | — | 1.4% |
| NL | — | 0.7% |
| IL | — | 0.6% |
| BM | 0.6% | 0.5% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FTXH and RYHIX overlap?
What stocks do FTXH and RYHIX have in common?
Should I own both FTXH and RYHIX?
Which holds more stocks, FTXH or RYHIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.